Evidence map›Paper›PMID 42004409›Full record

ReviewVeterinary evidence

Does grapiprant reduce osteoarthritic pain in dogs?

Grace Olding, Merran Govendir

Abstract readReview
In one paragraph

Review in Veterinary evidence. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Grace OldingThe University of Sydney Australia.ORCID https://orcid.org/0000-0001-6360-6825
Merran GovendirThe University of Sydney Australia.ORCID https://orcid.org/0000-0003-3595-0500

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PICO question: In dogs with osteoarthritis, does grapiprant, compared with no grapiprant, reduce osteoarthritic pain? Clinical bottom line: Category of research: Treatment. Number and type of study designs reviewed: Two randomised controlled trials. Strength of evidence: Weak. Outcomes reported: One study found that dogs with osteoarthritis given grapiprant were found to have significant clinical improvement in both owner assessed outcomes (treatment successes, pain interference scores, pain severity scores) and veterinarian assessed outcomes (total orthopaedic scores) when compared to a placebo. The second study of dogs with acute induced arthritis found no significant differences in vertical force ratios or veterinarian assessed visual lameness scores between dogs administered grapiprant and the control group. Conclusion: These studies suggest that grapiprant reduces the impact of osteoarthritic pain on activities of daily living and orthopaedic scores in dogs but does not improve lameness associated with acute, severe osteoarthritic pain. Given the limited and inconsistent evidence, further appropriate studies are required to determine the efficacy of grapiprant in managing osteoarthritic pain in dogs. How to apply this evidence in practice The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient's circumstances and owners' values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources.Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.

Indexed as

CANINEDOGEP-4 ANTAGONISTGRAPIPRANTOSTEOARTHRITIS

Identifiers

PMID42004409
PMCPMC13082424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.